Motley Bio
Digitizing Biology Through Multiomics
- Headquarters
- San Francisco, California
- Business Model
- B2B
- Website
- motley.bio
- Last Round
- Pre-SeedDec 2024
- Rounds
- 1
About
Motley Bio is a San Francisco-based biotechnology company digitizing biology through multiomics, with a vision of a future where the full spectrum of biological information can be captured and understood. The company is building a unified multi-omics platform aimed at unlocking early disease biology, and has shown progress on the platform at venues including the AACR Annual Meeting. Motley Bio was also selected for the BioTools Innovator 2026 Cohort alongside peers such as HelioWave Technologies and Millennial Scientific.
Summary
Motley Bio is a Healthcare company based in San Francisco, United States. Its most recent funding was a Pre-Seed round in Dec 2024. Investors include Plug and Play.
Funding History
Dec 2024
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
China's leading blood products manufacturer
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/motley-bio"><img src="https://indexed.vc/api/badge/company/motley-bio" alt="Motley Bio on Indexed.vc" width="260" height="76" /></a>